Back to search results

Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)

Abroad (travel likely)RecruitingPHASE2

Conditions

Multiple Myeloma · Amyloidosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of Alabama at Birmingham, Birmingham, Alabama, United States

    Contact: Study coordinator (Luciano J Costa, MD, PhD) · ljcosta@uabmc.edu · 205-934-1908
    Contact: Principal Investigator (Susan Bal, MD)
    Luciano J Costa, MD, PhD (Sub-investigator)
    Kelly Godby, MD (Sub-investigator)
    Gayathri Ravi, MD (Sub-investigator)
    Heidi Worth, MD (Sub-investigator)
Study leads

  • Susan Bal, MD

    Principal Investigator

    University of Alabama at Birmingham

View source on ClinicalTrials.gov(opens in a new tab)